Status:
COMPLETED
The Efficacy and Safety of Trapezius MSAT on Acute Whiplash Injury
Lead Sponsor:
Jaseng Medical Foundation
Conditions:
Whiplash Injury of Cervical Spine
Neck Pain, Posterior
Eligibility:
All Genders
19-70 years
Phase:
NA
Brief Summary
This study is a double blind, randomized controlled trail. condition/disease: acute neck pain treatment/intervention: motion style acupuncture treatment
Detailed Description
Motion Style Acupuncture Treatment(MSAT) is a therapeutic technique using acupuncture needle created in Jaseng Hospital. This treatment involves patients with musculoskeletal pain to move the part of ...
Eligibility Criteria
Inclusion
- Patients who needs hospitalization due to acute whiplash injury that occurred within 7 days after traffic accident
- Patients with NRS ≥ 5 for posterior neck pain
- Patients aged 19-70 years on the date they sign the consent form
- Patients who provide consent to participate in the trial and return the informed consent form
Exclusion
- Patients with a specific serious disease that may cause spinal pain: malignancy, spondylitis, inflammatory spondylitis, etc.
- Patients with progressive neurological deficits or with severe neurological symptoms
- Patients who have had surgery or procedures within the last three weeks
- The cause of pain is due to soft tissue disease, not the spine: tumors, fibromyalgia, rheumatoid arthritis, gout, etc.
- Patients with other chronic conditions that may interfere with the interpretation of the therapeutic effects or results: cardiovascular disease, kidney disease, diabetic neuropathy, dementia, epilepsy, etc.
- Patients who are taking steroids, immunosuppressants, mental illness drugs, or other drugs that may affect the results of the study
- If acupuncture is inadequate or unsafe: patients with hemorrhagic, receiving anticoagulants, severe diabetes and cardiovascular disease
- Patients who are pregnant or planning to become pregnant
- Patients with a serious mental illness
- Patients who are participated in clinical trials other than observational studies without therapeutic intervention.
- Patients who are difficult to complete the research participation agreement
- Other patients whose participation in the trial is judged by a researcher to be problematic
Key Trial Info
Start Date :
July 3 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 15 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04113824
Start Date
July 3 2019
End Date
December 15 2019
Last Update
March 27 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Jaseng Hospital of Korean Medicine
Seoul, Gangnam-Gu, South Korea, 135-896
2
Jaseng Medical Foundation
Seoul, South Korea